Impact of Fluoropyrimidine and Oxaliplatin-based Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer

Conclusion: The addition of OX to an FP regimen in neoadjuvant CRT for LARC may reduce local recurrence in patients who have achieved good compliance to CRT.

Source: In Vivo - January 5, 2021 Category: Research Authors: OKADA, Y., OZAWA, T., HAYAMA, T., OHNO, K., TSUKAMOTO, M., FUKUSHIMA, Y., SHIMADA, R., NOZAWA, K., MATSUDA, K., HASHIGUCHI, Y. Tags: Clinical Studies Source Type: research